Getinge (OTCMKTS:GNGBY) Sees Unusually-High Trading Volume – Time to Buy?

Shares of Getinge (OTCMKTS:GNGBY) saw an uptick in trading volume on Monday . 1,764 shares traded hands during trading, a decline of 17% from the previous session’s volume of 2,117 shares.The stock last traded at $23.89 and had previously closed at $24.3750.

Wall Street Analysts Forecast Growth

Separately, Nordea Equity Research upgraded Getinge from a “hold” rating to a “buy” rating in a report on Wednesday, October 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Getinge Trading Down 1.5%

The company has a market capitalization of $6.50 billion, a P/E ratio of 31.81 and a beta of 1.06. The business has a 50 day moving average price of $22.87 and a 200 day moving average price of $21.95. The company has a current ratio of 1.34, a quick ratio of 0.80 and a debt-to-equity ratio of 0.31.

Getinge (OTCMKTS:GNGBY) last issued its quarterly earnings data on Tuesday, October 21st. The company reported $0.25 earnings per share (EPS) for the quarter. Getinge had a net margin of 5.77% and a return on equity of 10.64%. The firm had revenue of $864.74 million during the quarter.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.